Patent Board Denies Mylan Bid For Review Of Taxoid Patent
(Decision available. Document #16-160906-017Z.)
Aventis has asserted its U.S. patent No. 5,847,170 in several lawsuits still pending in the U.S. District Court for the District of New Jersey, including Sanofi-Aventis U.S. LLC, Aventis Pharma...
To view the full article, register now.